Advancing vaccine development for African swine fever
This EU funding program, 'Advancing vaccine development for African swine fever' (HORIZON-CL6-2023-FARM2FORK-01-5), aims to significantly reduce the impact of African swine fever by fostering advanced vaccine research and development. It supports initiatives that safeguard animal health and enhance the economic resilience of the sustainable livestock industry through innovative solutions.
Who is Funded for African Swine Fever Vaccine Development
This section provides an overview of the eligible participants for the 'Advancing vaccine development for African swine fever' program, detailing the types of entities and individuals who can apply, the geographical scope of the funded projects, and the overarching objectives the program aims to achieve.
What Research is Funded for African Swine Fever Vaccines
This section outlines the types of projects and thematic areas eligible for funding under the 'Advancing vaccine development for African swine fever' program. It specifies the key sectors supported and the developmental stages of projects that can receive financial assistance.
Type and Scope of Funding for ASF Vaccine Initiatives
This section details the financial aspects of the 'Advancing vaccine development for African swine fever' program, including the type of financial support provided and the maximum funding available per project.
Conditions and Requirements for ASF Vaccine Projects
This section outlines the essential rules, regulations, and specific conditions that applicants and beneficiaries must adhere to when participating in the 'Advancing vaccine development for African swine fever' program. It covers application terms, collaboration requirements, and other important provisions.
Application and Selection for ASF Vaccine Funding
This section provides an overview of the application and selection procedures for the 'Advancing vaccine development for African swine fever' funding program. It outlines the submission process, evaluation methods, and how applicants are informed of decisions.
Legal Basis for ASF Vaccine Development Funding
This section identifies the foundational legal and official documents that underpin the 'Advancing vaccine development for African swine fever' funding program, ensuring transparency and adherence to established European Union regulations and policies.
Similar Programs
Funding Overview
Funding Status:
Closed
Maximum Amount:
6,000,000 €
Allocated Budget:
12,000,000 €
Deadline:
12.04.2023
Open Until:
Closed
Award Channel:
Framework Programme Call
Region:
European Union, Multi-Country (International cooperation particularly with North America is encouraged)
Sectors:
Healthcare, Research and Development, Agriculture and Agribusiness
Beneficiaries:
Livestock industry, domestic pigs, wild boars, farmers
Application Type:
Consortium Required
Funding Stages:
Applied Research, Experimental Development
Funding Provider
Program Level:
European Union
Funding Body:
European Commission
Managed By:
Research Executive Agency
Additional Partners:
EIT Knowledge and Innovation Communities (e.g., EIT Food), European Commission Knowledge Centre for Global Food and Nutrition Security, Africa Knowledge Platform, Star-Idaz International Consortium, VACDIVA project, DEFEND project.
Website: